| Lexi-Comp''s Pharmacogenomics Handbook 2nd Edition Larissa M Cavallari, Vicki L Ellingrod, Jill M Kolesar. Lexi-Comp Inc, Ohio, 2005 | |
| Gardiner SJ and Begg EJ. Pharmacogenomics, Drug-Metabolising Enzymes, and Clinical Practice. Pharmacological Reviews 58:521-590, 2006 http://www.ncbi.nlm.nih.gov/pubmed/158641http://www.ncbi.nlm.nih.gov/pubmed/12180536 | |
| Hansten PD and Horn JR. The Top 100 Drug Interactions-a Guide to Patient Management2009 edition H&H PublicationsFreeland,WA,USA www.hanstenandhorn.com | |
| Pharmacogenomics;second edition. Eds Werner Kalow, Urs A. Meyer, Rachel F. Tyndale Taylor and Francis, Florida 2005 | |
| Kirchheiner, J., Nickchen, K., Bauer, M., Wong, M. L., Licinio, J., Roots, I., and Brockmoller, J. Pharmacogenomics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response. Kirchheiner J et al. Mol.Psychiatry 9(5), www.ncbi.nlm.nih.gov/pubmed/15037866 | |
| Australian Medicines Handbook. ed Simone Rossi, Australian Medicine Handbook Proprietry Ltd, Adelaide 2006 www.amh.net.au | |
| Sandson NB. Drug Drug Interaction Primer- a compendium of case vignettes for the practicing clinician http://books.google.com.au/books?id=bifEX3O7lNkC&printsec=frontcover&dq=sertraline+inhibits+dose+dependent&ie=ISO-8859-1&output=html&source=gbs_summary_s&cad=0 | |
| Sheffield LJ and Phillimore HE. Clinical Pharmacogenomic Tests in 2009 The Clinical Biochemist reviews.30: 55-65 2009 | |
| Wynn GH, Oesterheld JR, Cozza KL and Armstrong SC. Clinical Manual of Drug Interaction. Principles for Medical Practice.American Psychiatric Publishing Inc., Arlington VA, 2009 | |